Tocilizumab (IMAGE)

University of California - San Diego

Tocilizumab

Caption

Tocilizumab, marketed as Actemra, is approved for treatment of rheumatoid arthritis. It is being assessed as a potential treatment for COVID-19-related pneumonia.

Credit

Roche

Usage Restrictions

Must use photo credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.